Forest and Actavis settle over blood pressure drug

08-11-2013

US pharmaceutical company Forest Laboratories and drug company Actavis have settled a legal dispute over a patent protecting blood pressure drug Bystoli (nebivolol).


Forest Laboratories, Actavis, Bystoli, hypertension

LSIPR